{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:32:48Z","timestamp":1784565168826,"version":"3.55.0"},"reference-count":361,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.clbc.2025.09.008","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T03:56:09Z","timestamp":1758599769000},"page":"732-763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["From Molecules to Medicine: Molecular Dynamics and Docking in Breast Cancer Therapeutics"],"prefix":"10.1016","volume":"25","author":[{"given":"Reza","family":"Bozorgpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clbc.2025.09.008_bib0001","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0002","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.canlet.2013.09.043","article-title":"Epigenetics and cancer metabolism","volume":"356","author":"Johnson","year":"2015","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0003","first-page":"31","article-title":"Breast cancer statistics, 2015: convergence of incidence rates between black and white women","volume":"66","author":"DeSantis","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0004","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/CEJ.0000000000000056","article-title":"Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening","volume":"24","author":"Gordon","year":"2015","journal-title":"Eur J Cancer Prev"},{"issue":"7123","key":"10.1016\/j.clbc.2025.09.008_bib0005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature05384","article-title":"Identification and expansion of human colon-cancer-initiating cells","volume":"445","author":"Ricci-Vitiani","year":"2007","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.clbc.2025.09.008_bib0006","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.ejrad.2011.03.020","article-title":"PET\/CT imaging in different types of lung cancer: an overview","volume":"81","author":"Ambrosini","year":"2012","journal-title":"Eur J Radiol"},{"issue":"9","key":"10.1016\/j.clbc.2025.09.008_bib0007","doi-asserted-by":"crossref","first-page":"djw042","DOI":"10.1093\/jnci\/djw042","article-title":"Adjuvant radiation therapy and chemotherapy in Merkel cell carcinoma: survival analyses of 6908 cases from the National Cancer Data Base","volume":"108","author":"Bhatia","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0008","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nri2216","article-title":"Immunological aspects of cancer chemotherapy","volume":"8","author":"Zitvogel","year":"2008","journal-title":"Nat rev Immunol"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0009","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1158\/2159-8290.CD-16-0241","article-title":"Cellular senescence promotes adverse effects of chemotherapy and cancer relapse","volume":"7","author":"Demaria","year":"2017","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.semradonc.2011.09.003","article-title":"Rational use of intensity-modulated radiation therapy: the importance of clinical outcome","volume":"22","author":"De Neve","year":"2012","journal-title":"Semin Radiat Onco"},{"issue":"7","key":"10.1016\/j.clbc.2025.09.008_bib0011","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/0008-5472.CAN-16-1536","article-title":"Surgery for cancer: a trigger for metastases","volume":"77","author":"Tohme","year":"2017","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-015-0310-1","article-title":"Malignant hyperthermia: a review","volume":"10","author":"Rosenberg","year":"2015","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10.1016\/j.clbc.2025.09.008_bib0013","doi-asserted-by":"crossref","DOI":"10.1063\/1.4935688","article-title":"Fundamentals and advances in magnetic hyperthermia","volume":"2","author":"Perigo","year":"2015","journal-title":"Appl Phys Rev"},{"key":"10.1016\/j.clbc.2025.09.008_bib0014","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.compbiomed.2017.03.009","article-title":"Phase change heat transfer during cryosurgery of lung cancer using hyperbolic heat conduction model","volume":"84","author":"Kumar","year":"2017","journal-title":"Comput Biol Med"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0015","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.nano.2017.11.018","article-title":"Nanoparticle-mediated cryosurgery for tumor therapy","volume":"14","author":"Hou","year":"2018","journal-title":"Nanomedicine"},{"issue":"23","key":"10.1016\/j.clbc.2025.09.008_bib0016","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Mokhtari","year":"2017","journal-title":"Oncotarget"},{"issue":"22","key":"10.1016\/j.clbc.2025.09.008_bib0017","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.2174\/0929867323666160425113705","article-title":"An update on phytochemicals in molecular target therapy of cancer: potential inhibitory effect on telomerase activity","volume":"23","author":"Alibakhshi","year":"2016","journal-title":"Curr Med Chem"},{"issue":"3","key":"10.1016\/j.clbc.2025.09.008_bib0018","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/CCO.0b013e3283521349","article-title":"Personalized management of patients with solid cancers: moving from patient characteristics to tumor biology","volume":"24","author":"Awada","year":"2012","journal-title":"Curr Opin Oncol"},{"issue":"7172","key":"10.1016\/j.clbc.2025.09.008_bib0019","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/nature06522","article-title":"Dynamic personalities of proteins","volume":"450","author":"Henzler-Wildman","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.clbc.2025.09.008_bib0020","unstructured":"Dubochet J, Frank J, Henderson R. The Nobel Prize in Chemistry 2017. Nobel Media AB. 2017. Available from: https:\/\/www.nobelprize.org\/prizes\/chemistry\/2017\/summary\/. Accessed Date 2025 Oct 8."},{"key":"#cr-split#-10.1016\/j.clbc.2025.09.008_bib0021.1","unstructured":"Bozorgpour R, Sheybanikashani S, Mohebi M. Exploring the role of molecular dynamics simulations in most recent cancer research: insights into treatment strategies. arXiv [Preprint]. 2023 Oct 30 [updated 2025 Feb 6"},{"key":"#cr-split#-10.1016\/j.clbc.2025.09.008_bib0021.2","unstructured":"Accessed 2025 Oct 8]. arXiv:2310.19950. Available from: https:\/\/arxiv.org\/abs\/2310.19950. doi:10.48550\/arXiv.2310.19950."},{"issue":"3","key":"10.1016\/j.clbc.2025.09.008_bib0022","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1042\/BJ20110369","article-title":"Aggregation of amyloids in a cellular context: modelling and experiment","volume":"438","author":"Friedman","year":"2011","journal-title":"Biochemical J"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0023","article-title":"From bytes to bedside: data integration and computational biology for translational cancer research","volume":"3","author":"Mathew","year":"2007","journal-title":"PLoS comput Bio"},{"issue":"4","key":"10.1016\/j.clbc.2025.09.008_bib0024","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/embor.2009.46","article-title":"From cancer genomes to cancer models: bridging the gaps","volume":"10","author":"Baudot","year":"2009","journal-title":"EMBO Rep"},{"issue":"3","key":"10.1016\/j.clbc.2025.09.008_bib0025","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrc2808","article-title":"Dissecting cancer through mathematics: from the cell to the animal model","volume":"10","author":"Byrne","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0026","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.pbiomolbio.2011.03.002","article-title":"Systems biology and cancer: promises and perils","volume":"106","author":"Baker","year":"2011","journal-title":"Prog Biophys Mol Biol"},{"issue":"9","key":"10.1016\/j.clbc.2025.09.008_bib0027","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1021\/acs.jmedchem.5b01684","article-title":"Role of molecular dynamics and related methods in drug discovery","volume":"59","author":"De Vivo","year":"2016","journal-title":"J Med Chem"},{"issue":"5","key":"10.1016\/j.clbc.2025.09.008_bib0028","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2741\/3809","article-title":"Bridging quantum mechanics and structure-based drug design","volume":"16","author":"De Vivo","year":"2011","journal-title":"Front Biosci"},{"issue":"19","key":"10.1016\/j.clbc.2025.09.008_bib0029","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1021\/ja00124a002","article-title":"A second generation force field for the simulation of proteins, nucleic acids, and organic molecules","volume":"117","author":"Cornell","year":"1995","journal-title":"J Am Chem Soc"},{"issue":"18","key":"10.1016\/j.clbc.2025.09.008_bib0030","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1021\/jp973084f","article-title":"All-atom empirical potential for molecular modeling and dynamics studies of proteins","volume":"102","author":"MacKerell","year":"1998","journal-title":"J Phy Chem B"},{"issue":"6","key":"10.1016\/j.clbc.2025.09.008_bib0031","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1021\/ja00214a001","article-title":"The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin","volume":"110","author":"Jorgensen","year":"1988","journal-title":"J Am Chem Soc"},{"key":"#cr-split#-10.1016\/j.clbc.2025.09.008_bib0032.1","unstructured":"Bozorgpour R. Computational explorations in biomedicine: unraveling molecular dynamics for cancer, drug delivery, and biomolecular insights using LAMMPS simulations. arXiv [Preprint]. 2023 Nov 21 [updated 2024 Sep 4"},{"key":"#cr-split#-10.1016\/j.clbc.2025.09.008_bib0032.2","unstructured":"cited 2025 Oct 8]. arXiv:2311.13000. Available from: https:\/\/arxiv.org\/abs\/2311.13000. doi:10.48550\/arXiv.2311.13000."},{"issue":"9","key":"10.1016\/j.clbc.2025.09.008_bib0033","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J Comput chem"},{"issue":"4","key":"10.1016\/j.clbc.2025.09.008_bib0034","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J Comput chem"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","article-title":"Automatic atom type and bond type perception in molecular mechanical calculations","volume":"25","author":"Wang","year":"2006","journal-title":"J Molecular Grap"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0036","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/jcc.23775","article-title":"Paramfit: automated optimization of force field parameters for molecular dynamics simulations","volume":"36","author":"Betz","year":"2015","journal-title":"J Comput chem"},{"issue":"8","key":"10.1016\/j.clbc.2025.09.008_bib0037","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1021\/ct4003477","article-title":"Automated force field parameterization for nonpolarizable and polarizable atomic models based on ab initio target data","volume":"9","author":"Huang","year":"2013","journal-title":"J Chem Theory Comput"},{"issue":"11","key":"10.1016\/j.clbc.2025.09.008_bib0038","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1021\/jz500737m","article-title":"Building force fields: an automatic, systematic, and reproducible approach","volume":"5","author":"Wang","year":"2014","journal-title":"J Phys Chem lett"},{"key":"10.1016\/j.clbc.2025.09.008_sbref0039","series-title":"Understanding Molecular Simulation: From Algorithms to Applications","author":"Frenkel","year":"2023"},{"key":"10.1016\/j.clbc.2025.09.008_sbref0040","series-title":"Computer Simulation of Liquids","author":"Allen","year":"2017"},{"key":"10.1016\/j.clbc.2025.09.008_bib0041","doi-asserted-by":"crossref","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N log (N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J Chem Phys"},{"key":"10.1016\/j.clbc.2025.09.008_bib0042","doi-asserted-by":"crossref","first-page":"578","DOI":"10.2741\/4229","article-title":"Molecular mechanics and dynamics: numerical tools to sample the configuration space","volume":"19","author":"Masetti","year":"2014","journal-title":"Front Biosci"},{"key":"10.1016\/j.clbc.2025.09.008_bib0043","first-page":"51","article-title":"Polarizable force fields for biomolecular modeling","volume":"28","author":"Shi","year":"2015","journal-title":"Rev Comput Chem"},{"issue":"17","key":"10.1016\/j.clbc.2025.09.008_bib0044","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.1073\/pnas.0711686105","article-title":"Calculation of protein\u2013ligand binding free energy by using a polarizable potential","volume":"105","author":"Jiao","year":"2008","journal-title":"Pro National Acad Sci"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0045","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0022-2836(76)90311-9","article-title":"Theoretical studies of enzymic reactions: dielectric, electrostatic and steric stabilization of the carbonium ion in the reaction of lysozyme","volume":"103","author":"Warshel","year":"1976","journal-title":"J Mol Biol"},{"issue":"17-18","key":"10.1016\/j.clbc.2025.09.008_bib0046","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.drudis.2007.07.006","article-title":"The role of quantum mechanics in structure-based drug design","volume":"12","author":"Raha","year":"2007","journal-title":"Drug Disc Today"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0047","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/156802610790232242","article-title":"Quantum mechanical methods for drug design","volume":"10","author":"Zhou","year":"2010","journal-title":"Curr Topics Med chem"},{"issue":"9","key":"10.1016\/j.clbc.2025.09.008_bib0048","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1021\/cr050579p","article-title":"Target-related applications of first principles quantum chemical methods in drug design","volume":"106","author":"Cavalli","year":"2006","journal-title":"Chem Rev"},{"issue":"41","key":"10.1016\/j.clbc.2025.09.008_bib0049","doi-asserted-by":"crossref","first-page":"9396","DOI":"10.1021\/jp004368u","article-title":"ReaxFF: a reactive force field for hydrocarbons","volume":"105","author":"Van Duin","year":"2001","journal-title":"J Phy Chem"},{"issue":"7","key":"10.1016\/j.clbc.2025.09.008_bib0050","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/prot.24499","article-title":"Constant pH molecular dynamics of proteins in explicit solvent with proton tautomerism","volume":"82","author":"Goh","year":"2014","journal-title":"Proteins"},{"issue":"3","key":"10.1016\/j.clbc.2025.09.008_bib0051","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1021\/ct401042b","article-title":"Constant pH replica exchange molecular dynamics in explicit solvent using discrete protonation states: implementation, testing, and validation","volume":"10","author":"Swails","year":"2014","journal-title":"J Chem Theory Comput"},{"issue":"6","key":"10.1016\/j.clbc.2025.09.008_bib0052","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1021\/ct200061r","article-title":"Constant pH molecular dynamics in explicit solvent with \u03bb-dynamics","volume":"7","author":"Donnini","year":"2011","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.clbc.2025.09.008_bib0053","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1574-1400(09)00502-7","article-title":"Quantifying uncertainty and sampling quality in biomolecular simulations","volume":"5","author":"Grossfield","year":"2009","journal-title":"Ann Rep Comput Chem"},{"issue":"3","key":"10.1016\/j.clbc.2025.09.008_bib0054","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0006-3495(97)78756-3","article-title":"The statistical-thermodynamic basis for computation of binding affinities: a critical review","volume":"72","author":"Gilson","year":"1997","journal-title":"Biophy J"},{"issue":"8","key":"10.1016\/j.clbc.2025.09.008_bib0055","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1021\/ct100255z","article-title":"A note on the standard state\u2019s binding free energy","volume":"6","author":"General","year":"2010","journal-title":"J Chem Theory Comput"},{"issue":"9","key":"10.1016\/j.clbc.2025.09.008_bib0056","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/jcc.21776","article-title":"Determining equilibrium constants for dimerization reactions from molecular dynamics simulations","volume":"32","author":"De Jong","year":"2011","journal-title":"J Comput chem"},{"issue":"8","key":"10.1016\/j.clbc.2025.09.008_bib0057","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1021\/jm801385d","article-title":"Barril X. binding site detection and druggability index from first principles","volume":"52","author":"Seco","year":"2009","journal-title":"J Med Chem"},{"issue":"7","key":"10.1016\/j.clbc.2025.09.008_bib0058","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1021\/ct300117j","article-title":"Druggability assessment of allosteric proteins by dynamics simulations in the presence of probe molecules","volume":"8","author":"Bakan","year":"2012","journal-title":"J Chem Theory Comput"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0059","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/e16010163","article-title":"Enhanced sampling in molecular dynamics using metadynamics, replica-exchange, and temperature-acceleration","volume":"16","author":"Abrams","year":"2013","journal-title":"Entropy"},{"key":"10.1016\/j.clbc.2025.09.008_bib0060","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/978-1-59745-177-2_19","article-title":"Molecular docking","author":"Morris","year":"2008","journal-title":"Methods Mol Bio"},{"issue":"4","key":"10.1016\/j.clbc.2025.09.008_bib0061","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1367-5931(02)00339-3","article-title":"Lead discovery using molecular docking","volume":"6","author":"Shoichet","year":"2002","journal-title":"Curr Opin Chem Biol"},{"issue":"23","key":"10.1016\/j.clbc.2025.09.008_bib0062","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.1021\/jm0608356","article-title":"Benchmarking sets for molecular docking","volume":"49","author":"Huang","year":"2006","journal-title":"J Med Chem"},{"issue":"12","key":"10.1016\/j.clbc.2025.09.008_bib0063","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.2174\/138945008786949432","article-title":"Molecular docking algorithms","volume":"9","author":"Dias","year":"2008","journal-title":"Curr Drug Targets"},{"issue":"5","key":"10.1016\/j.clbc.2025.09.008_bib0064","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/jmr.2266","article-title":"Latest developments in molecular docking: 2010\u20132011 in review","volume":"26","author":"Yuriev","year":"2013","journal-title":"J Mol Recognit"},{"issue":"11","key":"10.1016\/j.clbc.2025.09.008_bib0065","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nrd1549","article-title":"Docking and scoring in virtual screening for drug discovery: methods and applications","volume":"3","author":"Kitchen","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0066","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/(SICI)1099-1352(199603)9:2<175::AID-JMR260>3.0.CO;2-D","article-title":"Molecular docking towards drug discovery","volume":"9","author":"Gschwend","year":"1996","journal-title":"J Mol Recognit"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0067","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/mp.53.1.8","article-title":"x Ray crystallography","volume":"53","author":"Smyth","year":"2000","journal-title":"Molecular Pathology"},{"key":"10.1016\/j.clbc.2025.09.008_bib0068","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fmolb.2020.00009","article-title":"NMR methods for structural characterization of protein-protein complexes","volume":"7","author":"Purslow","year":"2020","journal-title":"Front Mol Biosci"},{"issue":"3","key":"10.1016\/j.clbc.2025.09.008_bib0069","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/030631277300300303","article-title":"The development of specialties in science: the case of X-ray protein crystallography","volume":"3","author":"Law","year":"1973","journal-title":"Science Studies"},{"issue":"9","key":"10.1016\/j.clbc.2025.09.008_bib0070","doi-asserted-by":"crossref","first-page":"7835","DOI":"10.3390\/ijms24097835","article-title":"Recent advances in NMR protein structure prediction with ROSETTA","volume":"24","author":"Koehler Leman","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0071","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1021\/acs.energyfuels.0c03382","article-title":"Application of nuclear magnetic resonance (NMR) spectroscopy to lacustrine kerogen geochemistry: Paleogene Dongpu Sag, China","volume":"35","author":"Gao","year":"2021","journal-title":"Energy & Fuels"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0072","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.clbc.2025.09.008_bib0073","unstructured":"Prize N. 2025 [Available from: https:\/\/www.nobelprize.org\/all-nobel-prizes-2024\/#:~:text=The%20Nobel%20Prize%20in%20Chemistry,design%20and%20protein%20structure%20prediction. Accessed October 8, 2025."},{"issue":"12","key":"10.1016\/j.clbc.2025.09.008_bib0074","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/prot.26257","article-title":"Applying and improving AlphaFold at CASP14","volume":"89","author":"Jumper","year":"2021","journal-title":"Proteins"},{"key":"10.1016\/j.clbc.2025.09.008_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2025.109842","article-title":"Advancements in protein structure prediction: a comparative overview of AlphaFold and its derivatives","volume":"188","author":"Malhotra","year":"2025","journal-title":"Comput Biol Med"},{"issue":"D1","key":"10.1016\/j.clbc.2025.09.008_bib0076","doi-asserted-by":"crossref","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","article-title":"AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models","volume":"50","author":"Varadi","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"6110","key":"10.1016\/j.clbc.2025.09.008_bib0077","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1126\/science.1219021","article-title":"The protein-folding problem, 50 years on","volume":"338","author":"Dill","year":"2012","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0078","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12551-016-0247-1","article-title":"Software for molecular docking: a review","volume":"9","author":"Pagadala","year":"2017","journal-title":"Biophys Rev"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0079","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.tips.2014.12.001","article-title":"Beware of docking!","volume":"36","author":"Chen","year":"2015","journal-title":"Trends Pharmacol Sci"},{"issue":"20","key":"10.1016\/j.clbc.2025.09.008_bib0080","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1021\/jm050362n","article-title":"A critical assessment of docking programs and scoring functions","volume":"49","author":"Warren","year":"2006","journal-title":"J Med Chem"},{"issue":"4","key":"10.1016\/j.clbc.2025.09.008_bib0081","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1021\/ci700052x","article-title":"Comparison of topological, shape, and docking methods in virtual screening","volume":"47","author":"McGaughey","year":"2007","journal-title":"J Chem Inf Model"},{"issue":"6","key":"10.1016\/j.clbc.2025.09.008_bib0082","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","article-title":"Molecular dynamics simulation for all","volume":"99","author":"Hollingsworth","year":"2018","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0083","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrd.2017.232","article-title":"Automating drug discovery","volume":"17","author":"Schneider","year":"2018","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0084","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41231-019-0050-7","article-title":"Lost in translation: the valley of death across preclinical and clinical divide\u2013identification of problems and overcoming obstacles","volume":"4","author":"Seyhan","year":"2019","journal-title":"Transl Med Commun"},{"key":"10.1016\/j.clbc.2025.09.008_bib0085","first-page":"1","article-title":"Clinical features, treatment, and prognosis of SGLT2 inhibitors induced acute pancreatitis","author":"Li","year":"2024","journal-title":"Expert Opin Drug Saf"},{"issue":"5","key":"10.1016\/j.clbc.2025.09.008_bib0086","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/computers12050091","article-title":"Understanding of machine learning with deep learning: architectures, workflow, applications and future directions","volume":"12","author":"Taye","year":"2023","journal-title":"Computers"},{"issue":"4","key":"10.1016\/j.clbc.2025.09.008_bib0087","article-title":"Artificial intelligence: a powerful paradigm for scientific research","volume":"2","author":"Xu","year":"2021","journal-title":"Innovation"},{"key":"10.1016\/j.clbc.2025.09.008_bib0088","first-page":"28","article-title":"Machine learning and deep learning: methods, techniques, applications, challenges, and future research opportunities","author":"Patil","year":"2024","journal-title":"Trustworthy AI Industry Society"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0089","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40537-021-00444-8","article-title":"Review of deep learning: concepts, CNN architectures, challenges, applications, future directions","volume":"8","author":"Alzubaidi","year":"2021","journal-title":"J Big Data"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s44395-025-00007-3","article-title":"Artificial intelligence in drug discovery and development: transforming challenges into opportunities","volume":"1","author":"Kant","year":"2025","journal-title":"Disc Pharma Sci"},{"key":"10.1016\/j.clbc.2025.09.008_bib0091","article-title":"An improved random forest based on the classification accuracy and correlation measurement of decision trees","volume":"237","author":"Sun","year":"2024","journal-title":"Expert Syst App"},{"key":"10.1016\/j.clbc.2025.09.008_bib0092","series-title":"Machine learning and information processing: proceedings of ICMLIP","first-page":"367","article-title":"Image classification using convolutional neural network (CNN) and recurrent neural network (RNN): a review","volume":"2020","author":"Dhruv","year":"2019"},{"key":"10.1016\/j.clbc.2025.09.008_bib0093","doi-asserted-by":"crossref","DOI":"10.1016\/j.commatsci.2025.113904","article-title":"Hyperparameter optimization and neural architecture search algorithms for graph Neural Networks in cheminformatics","volume":"254","author":"Ebadi","year":"2025","journal-title":"Comput Mater Sci"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0094","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13321-023-00743-7","article-title":"Practical guidelines for the use of gradient boosting for molecular property prediction","volume":"15","author":"Boldini","year":"2023","journal-title":"J Cheminform"},{"key":"10.1016\/j.clbc.2025.09.008_bib0095","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.csbj.2017.05.002","article-title":"Resurrecting the dead (molecules)","volume":"15","author":"Zaucha","year":"2017","journal-title":"Comput Struct Biotechnol J"},{"issue":"3","key":"10.1016\/j.clbc.2025.09.008_bib0096","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1021\/ci034243x","article-title":"ESOL: estimating aqueous solubility directly from molecular structure","volume":"44","author":"Delaney","year":"2004","journal-title":"J Chem Inf Comput Sci"},{"issue":"4","key":"10.1016\/j.clbc.2025.09.008_bib0097","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.3390\/jtaer18040110","article-title":"A brief survey of machine learning and deep learning techniques for e-commerce research","volume":"18","author":"Zhang","year":"2023","journal-title":"J Theor Appl Electron Commer Res"},{"issue":"10","key":"10.1016\/j.clbc.2025.09.008_bib0098","doi-asserted-by":"crossref","first-page":"btae574","DOI":"10.1093\/bioinformatics\/btae574","article-title":"Chain-aware graph neural networks for molecular property prediction","volume":"40","author":"Wang","year":"2024","journal-title":"Bioinformatics"},{"key":"10.1016\/j.clbc.2025.09.008_bib0099","first-page":"39","article-title":"Scalable and adaptive deep learning algorithms for large-scale machine learning systems","volume":"4","author":"Rane","year":"2024","journal-title":"Future Res Opp AI Industry"},{"issue":"17","key":"10.1016\/j.clbc.2025.09.008_bib0100","doi-asserted-by":"crossref","first-page":"i821","DOI":"10.1093\/bioinformatics\/bty593","article-title":"DeepDTA: deep drug\u2013target binding affinity prediction","volume":"34","author":"\u00d6zt\u00fcrk","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.clbc.2025.09.008_bib0101","unstructured":"Chithrananda S, Grand G, Ramsundar B. ChemBERTa: large-scale self-supervised pretraining for molecular property prediction. arXiv preprint arXiv:2010.09885; 2020. Available from: https:\/\/arxiv.org\/abs\/2010.09885. Accessed October 8, 2025."},{"issue":"6","key":"10.1016\/j.clbc.2025.09.008_bib0102","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1007\/s42250-024-00976-5","article-title":"Revolution of artificial intelligence in computational chemistry breakthroughs","volume":"7","author":"Anjaneyulu","year":"2024","journal-title":"Chem Africa"},{"key":"10.1016\/j.clbc.2025.09.008_bib0103","unstructured":"AI-chemistry-landscape. [Available from: https:\/\/web.cas.org\/marketing\/pdf\/ai-chemistry-landscape.pdf."},{"issue":"W1","key":"10.1016\/j.clbc.2025.09.008_bib0104","doi-asserted-by":"crossref","first-page":"W469","DOI":"10.1093\/nar\/gkae254","article-title":"Deep-PK: deep learning for small molecule pharmacokinetic and toxicity prediction","volume":"52","author":"Myung","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"40","key":"10.1016\/j.clbc.2025.09.008_bib0105","doi-asserted-by":"crossref","first-page":"26545","DOI":"10.1021\/acsomega.1c03842","article-title":"Multitask CapsNet: an imbalanced data deep learning method for predicting toxicants","volume":"6","author":"Wang","year":"2021","journal-title":"ACS omega"},{"issue":"W1","key":"10.1016\/j.clbc.2025.09.008_bib0106","doi-asserted-by":"crossref","first-page":"W5","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0107","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13321-025-00976-8","article-title":"CardioGenAI: a machine learning-based framework for re-engineering drugs for reduced hERG liability","volume":"17","author":"Kyro","year":"2025","journal-title":"J Cheminform"},{"issue":"9","key":"10.1016\/j.clbc.2025.09.008_bib0108","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J Med Chem"},{"issue":"7","key":"10.1016\/j.clbc.2025.09.008_bib0109","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s11095-024-03725-y","article-title":"A combination of machine learning and PBPK modeling approach for pharmacokinetics prediction of small molecules in humans","volume":"41","author":"Li","year":"2024","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13321-020-00460-5","article-title":"Molecular representations in AI-driven drug discovery: a review and practical guide","volume":"12","author":"David","year":"2020","journal-title":"J Cheminform"},{"issue":"5","key":"10.1016\/j.clbc.2025.09.008_bib0111","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1603","article-title":"A review of molecular representation in the age of machine learning","volume":"12","author":"Wigh","year":"2022","journal-title":"WIREs Comput Mol Sci"},{"issue":"8","key":"10.1016\/j.clbc.2025.09.008_bib0112","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104067","article-title":"Advancing drug discovery with deep attention neural networks","volume":"29","author":"Lavecchia","year":"2024","journal-title":"Drug Disc Today"},{"key":"10.1016\/j.clbc.2025.09.008_bib0113","series-title":"Methods in Molecular Biology","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-4939-8639-2_5","article-title":"Impact of molecular descriptors on computational models","author":"Grisoni","year":"2018"},{"key":"10.1016\/j.clbc.2025.09.008_bib0114","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ymeth.2014.08.005","article-title":"Molecular fingerprint similarity search in virtual screening","volume":"71","author":"Cereto-Massagu\u00e9","year":"2015","journal-title":"Methods"},{"issue":"11","key":"10.1016\/j.clbc.2025.09.008_bib0115","doi-asserted-by":"crossref","first-page":"13521","DOI":"10.1007\/s10462-023-10466-8","article-title":"Deep learning modelling techniques: current progress, applications, advantages, and challenges","volume":"56","author":"Ahmed","year":"2023","journal-title":"Artif Intell Rev"},{"issue":"6557","key":"10.1016\/j.clbc.2025.09.008_bib0116","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.abj8754","article-title":"Accurate prediction of protein structures and interactions using a three-track neural network","volume":"373","author":"Baek","year":"2021","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0117","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/pr.112.007336","article-title":"Computational methods in drug discovery","volume":"66","author":"Sliwoski","year":"2014","journal-title":"Pharmacol Rev"},{"issue":"7","key":"10.1016\/j.clbc.2025.09.008_bib0118","first-page":"2254","article-title":"Systematic computational strategies for identifying protein targets and lead discovery","volume":"15","author":"Kataria","year":"2024","journal-title":"RSC MedChem"},{"issue":"3","key":"10.1016\/j.clbc.2025.09.008_bib0119","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2174\/1570180819666220922103109","article-title":"Molecular docking: principles, advances, and its applications in drug discovery","volume":"21","author":"Muhammed","year":"2024","journal-title":"Lett Drug Design Disc"},{"issue":"7792","key":"10.1016\/j.clbc.2025.09.008_bib0120","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41586-019-1923-7","article-title":"Improved protein structure prediction using potentials from deep learning","volume":"577","author":"Senior","year":"2020","journal-title":"Nature"},{"issue":"6637","key":"10.1016\/j.clbc.2025.09.008_bib0121","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1126\/science.ade2574","article-title":"Evolutionary-scale prediction of atomic-level protein structure with a language model","volume":"379","author":"Lin","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.clbc.2025.09.008_bib0122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/prot.24452","article-title":"Critical assessment of methods of protein structure prediction (CASP)\u2014round x","volume":"82","author":"Moult","year":"2014","journal-title":"Proteins"},{"issue":"11","key":"10.1016\/j.clbc.2025.09.008_bib0123","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1016\/j.drudis.2021.05.019","article-title":"De novo molecular design and generative models","volume":"26","author":"Meyers","year":"2021","journal-title":"Drug Disc Today"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0124","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13321-024-00916-y","article-title":"A systematic review of deep learning chemical language models in recent era","volume":"16","author":"Flores-Hernandez","year":"2024","journal-title":"J Cheminform"},{"issue":"11","key":"10.1016\/j.clbc.2025.09.008_bib0125","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1021\/acs.molpharmaceut.9b00500","article-title":"Deep convolutional generative adversarial network (dcGAN) models for screening and design of small molecules targeting cannabinoid receptors","volume":"16","author":"Bian","year":"2019","journal-title":"Molecular pharmaceutics"},{"issue":"20","key":"10.1016\/j.clbc.2025.09.008_bib0126","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1021\/acs.jcim.2c00838","article-title":"De novo drug design using reinforcement learning with graph-based deep generative models","volume":"62","author":"Atance","year":"2022","journal-title":"J Chem Inf Model"},{"issue":"1-2","key":"10.1016\/j.clbc.2025.09.008_bib0127","doi-asserted-by":"crossref","DOI":"10.1002\/minf.201700123","article-title":"Application of generative autoencoder in de novo molecular design","volume":"37","author":"Blaschke","year":"2018","journal-title":"Molecular informatics"},{"key":"10.1016\/j.clbc.2025.09.008_bib0128","unstructured":"Tang H, Li C, Kamei S, Yamanishi Y, Morimoto Y. Molecular generative adversarial network with multi-property optimization. arXiv preprint arXiv:2404.00081; 2024. Available from: https:\/\/arxiv.org\/abs\/2404.00081. Accessed October 8, 2025."},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0129","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13321-019-0397-9","article-title":"A de novo molecular generation method using latent vector based generative adversarial network","volume":"11","author":"Prykhodko","year":"2019","journal-title":"J Cheminform"},{"issue":"12","key":"10.1016\/j.clbc.2025.09.008_bib0130","article-title":"Deep generative molecular design reshapes drug discovery","volume":"3","author":"Zeng","year":"2022","journal-title":"Cell Rep Med"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0131","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41598-023-50834-6","article-title":"MedGAN: optimized generative adversarial network with graph convolutional networks for novel molecule design","volume":"14","author":"Macedo","year":"2024","journal-title":"Scientific Rep"},{"issue":"8","key":"10.1016\/j.clbc.2025.09.008_bib0132","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/ddr.22115","article-title":"Artificial intelligence revolutionizing drug development: Exploring opportunities and challenges","volume":"84","author":"Tiwari","year":"2023","journal-title":"Drug Development Res"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0133","doi-asserted-by":"crossref","DOI":"10.1016\/j.aichem.2023.100039","article-title":"Advances in Artificial Intelligence (AI)-assisted approaches in drug screening","volume":"2","author":"Singh","year":"2024","journal-title":"Artif Intell Chem"},{"key":"10.1016\/j.clbc.2025.09.008_bib0134","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105403","article-title":"Generative machine learning for de novo drug discovery: a systematic review","volume":"145","author":"Martinelli","year":"2022","journal-title":"Comput Biol Med"},{"issue":"18","key":"10.1016\/j.clbc.2025.09.008_bib0135","doi-asserted-by":"crossref","first-page":"10520","DOI":"10.1021\/acs.chemrev.8b00728","article-title":"Concepts of artificial intelligence for computer-assisted drug discovery","volume":"119","author":"Yang","year":"2019","journal-title":"Chemical reviews"},{"issue":"6","key":"10.1016\/j.clbc.2025.09.008_bib0136","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3390\/ph18060788","article-title":"The potential of artificial intelligence in pharmaceutical innovation: from drug discovery to clinical trials","volume":"18","author":"Malheiro","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.clbc.2025.09.008_bib0137","series-title":"Computational Approaches for Novel Therapeutic and Diagnostic Designing to Mitigate SARS-CoV-2 Infection","first-page":"335","article-title":"Absorption, distribution, metabolism, excretion, and toxicity assessment of drugs using computational tools","author":"Sucharitha","year":"2022"},{"key":"10.1016\/j.clbc.2025.09.008_bib0138","article-title":"hERG-toxicity prediction using traditional machine learning and advanced deep learning techniques","volume":"5","author":"Ylip\u00e4\u00e4","year":"2023","journal-title":"Current Res Toxicol"},{"issue":"12","key":"10.1016\/j.clbc.2025.09.008_bib0139","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.3390\/polym17121667","article-title":"Recent progress of artificial intelligence application in polymer materials","volume":"17","author":"Long","year":"2025","journal-title":"Polymers"},{"key":"10.1016\/j.clbc.2025.09.008_bib0140","article-title":"Machine-learning-driven QSPR models for energetic molecules: a review on safety and energetic properties prediction","author":"Gao","year":"2025","journal-title":"Chem Engin J Ad"},{"issue":"4","key":"10.1016\/j.clbc.2025.09.008_bib0141","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1021\/mp300023x","article-title":"ADMET evaluation in drug discovery. 12. Development of binary classification models for prediction of hERG potassium channel blockage","volume":"9","author":"Wang","year":"2012","journal-title":"Mol Pharma"},{"key":"10.1016\/j.clbc.2025.09.008_bib0142","first-page":"1461","article-title":"Artificial intelligence in drug discovery and development","author":"Mak","year":"2024","journal-title":"Drug Discov Today"},{"issue":"13","key":"10.1016\/j.clbc.2025.09.008_bib0143","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1080\/10643389.2025.2469868","article-title":"New trend on chemical structure representation learning in toxicology: in reviews of machine learning model methodology","volume":"55","author":"Zhang","year":"2025","journal-title":"Crit Rev Environ Sci Technol"},{"issue":"7","key":"10.1016\/j.clbc.2025.09.008_bib0144","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.3390\/pharmaceutics15071916","article-title":"Artificial intelligence in pharmaceutical technology and drug delivery design","volume":"15","author":"Vora","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.clbc.2025.09.008_bib0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.euromechsol.2022.104869","article-title":"Optimum design of nonlinear structures via deep neural network-based parameterization framework","volume":"98","author":"Mai","year":"2023","journal-title":"Eur J Mech -A\/Solids"},{"key":"10.1016\/j.clbc.2025.09.008_bib0146","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.toxlet.2017.07.175","article-title":"DeepTox: toxicity prediction using deep learning","volume":"280","author":"Klambauer","year":"2017","journal-title":"Toxicology Letters"},{"issue":"14","key":"10.1016\/j.clbc.2025.09.008_bib0147","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202300816","article-title":"The role of AI in drug discovery","volume":"25","author":"Abbas","year":"2024","journal-title":"Chembiochem"},{"issue":"22","key":"10.1016\/j.clbc.2025.09.008_bib0148","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e40265","article-title":"Therapeutic peptide development revolutionized: harnessing the power of artificial intelligence for drug discovery","volume":"10","author":"Hashemi","year":"2024","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.clbc.2025.09.008_bib0149","doi-asserted-by":"crossref","DOI":"10.5599\/admet.2772","article-title":"Leveraging machine learning models in evaluating ADMET properties for drug discovery and development","volume":"13","author":"Venkataraman","year":"2025","journal-title":"ADMET and DMPK"},{"issue":"7","key":"10.1016\/j.clbc.2025.09.008_bib0150","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1016\/j.apsb.2024.03.002","article-title":"In silico off-target profiling for enhanced drug safety assessment","volume":"14","author":"Liu","year":"2024","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0151","doi-asserted-by":"crossref","DOI":"10.1016\/j.aichem.2023.100011","article-title":"Application of artificial intelligence and machine learning in early detection of adverse drug reactions (ADRs) and drug-induced toxicity","volume":"1","author":"Yang","year":"2023","journal-title":"Artif Intell Chem"},{"issue":"7","key":"10.1016\/j.clbc.2025.09.008_bib0152","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"Ferreira","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.clbc.2025.09.008_bib0153","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3389\/fphar.2018.01089","article-title":"Empirical scoring functions for structure-based virtual screening: applications, critical aspects, and challenges","volume":"9","author":"Guedes","year":"2018","journal-title":"Front Pharmacol"},{"issue":"14","key":"10.1016\/j.clbc.2025.09.008_bib0154","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.3390\/molecules27144568","article-title":"Protein\u2013ligand docking in the machine-learning era","volume":"27","author":"Yang","year":"2022","journal-title":"Molecules"},{"issue":"23","key":"10.1016\/j.clbc.2025.09.008_bib0155","doi-asserted-by":"crossref","first-page":"8684","DOI":"10.1021\/acs.jcim.4c01116","article-title":"Improved prediction of ligand\u2013protein binding affinities by meta-modeling","volume":"64","author":"Lee","year":"2024","journal-title":"J Chem Inf Model"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0156","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s42004-025-01428-y","article-title":"Narrowing the gap between machine learning scoring functions and free energy perturbation using augmented data","volume":"8","author":"Valsson","year":"2025","journal-title":"Commun Chem"},{"key":"10.1016\/j.clbc.2025.09.008_bib0157","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ymeth.2020.06.016","article-title":"Machine learning and AI-based approaches for bioactive ligand discovery and GPCR-ligand recognition","volume":"180","author":"Raschka","year":"2020","journal-title":"Methods"},{"issue":"3","key":"10.1016\/j.clbc.2025.09.008_bib0158","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3390\/ph18030329","article-title":"Gnnseq: a sequence-based graph neural network for predicting protein\u2013ligand binding affinity","volume":"18","author":"Dandibhotla","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.clbc.2025.09.008_bib0159","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2021.102327","article-title":"Graph neural network approaches for drug-target interactions","volume":"73","author":"Zhang","year":"2022","journal-title":"Curr Opin Struct Biol"},{"issue":"14","key":"10.1016\/j.clbc.2025.09.008_bib0160","doi-asserted-by":"crossref","first-page":"eadn4397","DOI":"10.1126\/sciadv.adn4397","article-title":"Biomolecular dynamics with machine-learned quantum-mechanical force fields trained on diverse chemical fragments","volume":"10","author":"Unke","year":"2024","journal-title":"Science Advances"},{"issue":"5","key":"10.1016\/j.clbc.2025.09.008_bib0161","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109673","article-title":"Machine learning interatomic potential: bridge the gap between small-scale models and realistic device-scale simulations","volume":"27","author":"Wang","year":"2024","journal-title":"Iscience"},{"issue":"48","key":"10.1016\/j.clbc.2025.09.008_bib0162","doi-asserted-by":"crossref","first-page":"34249","DOI":"10.1039\/D3RA06375E","article-title":"Unsupervised deep learning for molecular dynamics simulations: a novel analysis of protein\u2013ligand interactions in SARS-CoV-2 M pro","volume":"13","author":"Mustali","year":"2023","journal-title":"RSC advances"},{"issue":"9","key":"10.1016\/j.clbc.2025.09.008_bib0163","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1021\/acs.jpclett.5c00217","article-title":"Accelerating molecular dynamics with a graph neural network: a scalable approach through E(q)C-GNN","volume":"16","author":"Maji","year":"2025","journal-title":"J Phys Chem Lett"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0164","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.drudis.2020.12.009","article-title":"Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: ways to make an impact, and why we are not there yet","volume":"26","author":"Bender","year":"2021","journal-title":"Drug Disc Today"},{"issue":"22","key":"10.1016\/j.clbc.2025.09.008_bib0165","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.3390\/molecules25225277","article-title":"Machine learning methods in drug discovery","volume":"25","author":"Patel","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.clbc.2025.09.008_bib0166","first-page":"683","article-title":"Beyond the\" black box\"","volume":"98","author":"Tschider","year":"2020","journal-title":"Denv L Rev"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0167","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12559-023-10179-8","article-title":"Interpreting black-box models: a review on explainable artificial intelligence","volume":"16","author":"Hassija","year":"2024","journal-title":"Cognit Comput"},{"key":"10.1016\/j.clbc.2025.09.008_bib0168","series-title":"2023 IEEE 13th Annual Computing and Communication Workshop and Conference (CCWC)","article-title":"System monitoring and data logging using PLX-DAQ for solar-powered oil well pumping","author":"Chidolue","year":"2023"},{"key":"10.1016\/j.clbc.2025.09.008_bib0169","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8597892","article-title":"New insights into the screening, prompt diagnosis, management, and prognosis of breast cancer","volume":"2020","author":"Domeyer","year":"2020","journal-title":"J Oncol"},{"key":"10.1016\/j.clbc.2025.09.008_bib0170","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3389\/fphar.2018.00923","article-title":"Bridging molecular docking to molecular dynamics in exploring ligand-protein recognition process: an overview","volume":"9","author":"Salmaso","year":"2018","journal-title":"Frontiers in Pharmacol"},{"issue":"4","key":"10.1016\/j.clbc.2025.09.008_bib0171","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3390\/molecules23040894","article-title":"Identification by molecular docking of homoisoflavones from Leopoldia comosa as ligands of estrogen receptors","volume":"23","author":"Grande","year":"2018","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.clbc.2025.09.008_bib0172","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1073\/pnas.1323719111","article-title":"Differential expression of estrogen receptor \u03b1, \u03b21, and \u03b22 in lobular and ductal breast cancer","volume":"111","author":"Huang","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0173","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5306\/wjco.v8.i2.120","article-title":"Targeted therapies in breast cancer: new challenges to fight against resistance","volume":"8","author":"Masoud","year":"2017","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.clbc.2025.09.008_bib0174","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-018-0472-8","article-title":"Estrogen alpha receptor antagonists for the treatment of breast cancer: a review","volume":"12","author":"Sharma","year":"2018","journal-title":"Chem Cent J"},{"issue":"14","key":"10.1016\/j.clbc.2025.09.008_bib0175","doi-asserted-by":"crossref","first-page":"16759","DOI":"10.1021\/acsomega.4c00906","article-title":"Estrogen receptor alpha binders for hormone-dependent forms of breast cancer: e-QSAR and molecular docking supported by X-ray resolved structures","volume":"9","author":"Masand","year":"2024","journal-title":"ACS omega"},{"key":"10.1016\/j.clbc.2025.09.008_bib0176","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fmolb.2019.00159","article-title":"Dynamics insights into the gain of flexibility by Helix-12 in ESR1 as a mechanism of resistance to drugs in breast cancer cell lines","volume":"6","author":"Khan","year":"2020","journal-title":"Front Mol Biosci"},{"issue":"21","key":"10.1016\/j.clbc.2025.09.008_bib0177","doi-asserted-by":"crossref","first-page":"12328","DOI":"10.1080\/07391102.2023.2175260","article-title":"Identification of HER2 inhibitors from curcumin derivatives using combination of in silico screening and molecular dynamics simulation","volume":"41","author":"Saibu","year":"2023","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43094-024-00748-5","article-title":"Leveraging computational approaches in identifying novel HER-2+ breast cancer potential therapeutics: integrating virtual screening and molecular dynamics simulation","volume":"11","author":"Bolaji","year":"2025","journal-title":"Futur J Pharm Sci"},{"issue":"4","key":"10.1016\/j.clbc.2025.09.008_bib0179","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s12033-023-00680-8","article-title":"Docking and molecular dynamics simulation revealed the potential inhibitory activity of amygdalin in triple-negative breast cancer therapeutics targeting the BRCT domain of BARD1 receptor","volume":"66","author":"Chatterjee","year":"2024","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.clbc.2025.09.008_bib0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107737","article-title":"Integrating biocomputational techniques for Breast cancer drug discovery via the HER-2, BCRA, VEGF and ER protein targets","volume":"168","author":"Odunitan","year":"2024","journal-title":"Comput Biol Med"},{"issue":"8","key":"10.1016\/j.clbc.2025.09.008_bib0181","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1080\/07391102.2024.2301766","article-title":"Computational insights into overcoming resistance mechanisms in targeted therapies for advanced breast cancer: focus on EGFR and HER2 co-inhibition","volume":"43","author":"Abdulaziz","year":"2025","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.clbc.2025.09.008_bib0182","article-title":"Identification of potential therapeutic dual inhibitors of EGFR\/HER2 in breast cancer","volume":"11","author":"Jethwa","year":"2024","journal-title":"Eur J Med Chem Rep"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0183","doi-asserted-by":"crossref","DOI":"10.31788\/RJC.2024.1728795","article-title":"In-silico analysis of N-phenyl pyrazoline derivates as potential of human epidermal growth receptor-2 (HER-2) inhibitor using molecular docking and MD simulations","volume":"17","author":"Satria","year":"2024","journal-title":"Rasayan J Chem"},{"key":"10.1016\/j.clbc.2025.09.008_bib0184","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139301","article-title":"Molecular structure, spectroscopic (FT-IR, NMR and UV\u2013Vis), electronic properties, molecular docking, and molecular dynamics studies on novel thiazolidinone derivative: a potent breast cancer drug","volume":"1318","author":"Koyambo-Konzapa","year":"2024","journal-title":"J Mol Struct"},{"key":"10.1016\/j.clbc.2025.09.008_bib0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.141375","article-title":"In silico characterization of indole-substituted densely functionalized pyrrole against breast cancer: integrating DFT, molecular docking, MD simulations, and ADME analysis","volume":"1328","author":"Mouli","year":"2025","journal-title":"J Mol Struct"},{"key":"10.1016\/j.clbc.2025.09.008_bib0186","article-title":"Repurposing antiviral drugs targeting the PARP-1 and HER2 pathways with multifaceted impacts through integrated network analysis and molecular mechanics","volume":"10","author":"Mugundan","year":"2025","journal-title":"Chem Phy Impact"},{"issue":"10","key":"10.1016\/j.clbc.2025.09.008_bib0187","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.31557\/APJCP.2024.25.10.3447","article-title":"Molecular docking and pharmacokinetic profiling of nab-paclitaxel as advanced chemotherapeutic agent against HER-2 positive breast cancer patients","volume":"25","author":"Mangilit","year":"2024","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"10.1016\/j.clbc.2025.09.008_bib0188","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2024.110832","article-title":"Novel HER2-based multi-epitope vaccine (HER2-MEV) against HER2-positive breast cancer: in silico design and validation","volume":"85","author":"Seadawy","year":"2024","journal-title":"Hum Immunol"},{"key":"10.1016\/j.clbc.2025.09.008_bib0189","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107686","article-title":"Design, synthesis and biological evaluation of novel quinazoline-derived EGFR\/HER-2 dual-target inhibitors bearing a heterocyclic-containing tail as potential anti-tumor agents","volume":"151","author":"Hao","year":"2024","journal-title":"Bioorg Chem"},{"issue":"5","key":"10.1016\/j.clbc.2025.09.008_bib0190","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1080\/07391102.2023.2207656","article-title":"The potential of phytochemicals against epidermal growth factor receptor tyrosine kinase (EGFRK): an insight from molecular dynamic simulations","volume":"42","author":"Rodosy","year":"2024","journal-title":"Biomol Struct Dyn"},{"issue":"385","key":"10.1016\/j.clbc.2025.09.008_bib0191","doi-asserted-by":"crossref","first-page":"385","DOI":"10.12688\/f1000research.146862.3","article-title":"Molecular docking and dynamics studies to identify novel active compounds targeting potential breast cancer receptor proteins from an indigenous herb Euphorbia thymifolia Linn","volume":"13","author":"Kumblekar","year":"2024","journal-title":"F1000Res"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0192","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s13205-024-04196-z","article-title":"MRPL24 drives breast cancer metastasis and stemness by targeting c-MYC, BRD4, and STAT3","volume":"15","author":"Khan","year":"2025","journal-title":"3 Biotech"},{"issue":"15","key":"10.1016\/j.clbc.2025.09.008_bib0193","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1242\/dev.091744","article-title":"Cdks, cyclins and CKIs: roles beyond cell cycle regulation","volume":"140","author":"Lim","year":"2013","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0194","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrd4504","article-title":"The history and future of targeting cyclin-dependent kinases in cancer therapy","volume":"14","author":"Asghar","year":"2015","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"10.1016\/j.clbc.2025.09.008_bib0195","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.3390\/ijms19103219","article-title":"The emerging role of cyclin-dependent kinases (CDKs) in pancreatic ductal adenocarcinoma","volume":"19","author":"Garc\u00eda-Reyes","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.clbc.2025.09.008_bib0196","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.3390\/ijms21061960","article-title":"The roles of cyclin-dependent kinases in cell-cycle progression and therapeutic strategies in human breast cancer","volume":"21","author":"Ding","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0197","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nrc.2016.138","article-title":"Cell cycle proteins as promising targets in cancer therapy","volume":"17","author":"Otto","year":"2017","journal-title":"Nature Rev Cancer"},{"issue":"5","key":"10.1016\/j.clbc.2025.09.008_bib0198","first-page":"1913","article-title":"CDK inhibitors in cancer therapy, an overview of recent development","volume":"11","author":"Zhang","year":"2021","journal-title":"Am J Cancer Res"},{"issue":"9","key":"10.1016\/j.clbc.2025.09.008_bib0199","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.180112","article-title":"Structural insights into the functional diversity of the CDK\u2013cyclin family","volume":"8","author":"Wood","year":"2018","journal-title":"Open Biology"},{"issue":"3","key":"10.1016\/j.clbc.2025.09.008_bib0200","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2174\/138945010790711978","article-title":"CDK inhibitors: from the bench to clinical trials","volume":"11","author":"Rizzolio","year":"2010","journal-title":"Curr Drug Targets"},{"issue":"7155","key":"10.1016\/j.clbc.2025.09.008_bib0201","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nature06046","article-title":"Cdk1 is sufficient to drive the mammalian cell cycle","volume":"448","author":"Santamar\u00eda","year":"2007","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.clbc.2025.09.008_bib0202","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc2602","article-title":"Cell cycle, CDKs and cancer: a changing paradigm","volume":"9","author":"Malumbres","year":"2009","journal-title":"Nature reviews cancer"},{"issue":"11","key":"10.1016\/j.clbc.2025.09.008_bib0203","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.tibs.2005.09.005","article-title":"Mammalian cyclin-dependent kinases","volume":"30","author":"Malumbres","year":"2005","journal-title":"Trends Biochem Sci"},{"issue":"6","key":"10.1016\/j.clbc.2025.09.008_bib0204","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/gb4184","article-title":"Cyclin-dependent kinases","volume":"15","author":"Malumbres","year":"2014","journal-title":"Genome biology"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0205","doi-asserted-by":"crossref","first-page":"6769","DOI":"10.1038\/ncomms7769","article-title":"CDK1 structures reveal conserved and unique features of the essential cell cycle CDK","volume":"6","author":"Brown","year":"2015","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.clbc.2025.09.008_bib0206","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3390\/ijms23031293","article-title":"Cell cycle-dependent transcription: the cyclin dependent kinase Cdk1 is a direct regulator of basal transcription machineries","volume":"23","author":"Enserink","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1779","key":"10.1016\/j.clbc.2025.09.008_bib0207","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2018.0227","article-title":"Connections between the cell cycle, cell adhesion and the cytoskeleton","volume":"374","author":"Jones","year":"2019","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0208","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tcb.2020.11.001","article-title":"CDK1, the other \u2018master regulator\u2019of autophagy","volume":"31","author":"Odle","year":"2021","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.clbc.2025.09.008_bib0209","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.canlet.2018.11.019","article-title":"Cyclin B1\/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance","volume":"443","author":"Xie","year":"2019","journal-title":"Cancer lett"},{"issue":"5","key":"10.1016\/j.clbc.2025.09.008_bib0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165715","article-title":"Cell cycle regulators in cancer cell metabolism","volume":"1866","author":"Leal-Esteban","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"6","key":"10.1016\/j.clbc.2025.09.008_bib0211","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1517\/13543784.2016.1169273","article-title":"Alvocidib (flavopiridol) for the treatment of chronic lymphocytic leukemia","volume":"25","author":"Wiernik","year":"2016","journal-title":"Expert Opin Investig Drugs"},{"issue":"11","key":"10.1016\/j.clbc.2025.09.008_bib0212","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.4155\/fmc-2017-0246","article-title":"Recent advances in CDK inhibitors for cancer therapy","volume":"10","author":"Heptinstall","year":"2018","journal-title":"Future Medicinal Chem"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0213","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12094-021-02688-5","article-title":"Cyclin-dependent kinase (CDK) inhibitors in solid tumors: a review of clinical trials","volume":"24","author":"Panagiotou","year":"2022","journal-title":"Clin Transl Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0214","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109808","article-title":"Quantitative differences between cyclin-dependent kinases underlie the unique functions of CDK1 in human cells","volume":"37","author":"Lau","year":"2021","journal-title":"Cell Rep"},{"issue":"7","key":"10.1016\/j.clbc.2025.09.008_bib0215","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm.2377","article-title":"Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition","volume":"17","author":"Johnson","year":"2011","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.clbc.2025.09.008_bib0216","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1073\/pnas.1115201109","article-title":"Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration","volume":"109","author":"Diril","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.clbc.2025.09.008_bib0217","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131568","article-title":"Discovery of triaromatic flexible agents bearing 1, 2, 3-Triazole with selective and potent anti-breast cancer activity and CDK9 inhibition supported by molecular dynamics","volume":"1249","author":"Ihmaid","year":"2022","journal-title":"J Mol Struct"},{"key":"10.1016\/j.clbc.2025.09.008_bib0218","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104748","article-title":"Development of isatin-thiazolo [3, 2-a] benzimidazole hybrids as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: synthesis, biological and molecular dynamics investigations","volume":"110","author":"Eldehna","year":"2021","journal-title":"Bioorg Chem"},{"issue":"38","key":"10.1016\/j.clbc.2025.09.008_bib0219","first-page":"39873","article-title":"Discovery of potential inhibitors of CDK1 by integrating pharmacophore-based virtual screening, molecular docking, molecular dynamics simulation studies, and evaluation of their inhibitory activity","volume":"9","author":"Teotia","year":"2024","journal-title":"ACS omega"},{"issue":"4","key":"10.1016\/j.clbc.2025.09.008_bib0220","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/10799893.2024.2430495","article-title":"Investigating the inhibitory potential of natural bioactive compounds against cyclin-dependent kinase 13: virtual high throughput screening and MD simulation studies to target CDK signaling","volume":"44","author":"Zehra","year":"2024","journal-title":"J Recept Signal Transduct"},{"issue":"4","key":"10.1016\/j.clbc.2025.09.008_bib0221","doi-asserted-by":"crossref","first-page":"788","DOI":"10.2174\/0109298673319832240829164046","article-title":"A molecular dynamic simulation, structural analysis, and Ex vivo insights into the p-glycoprotein mediated interactions of dietary polyphenols with cyclin-dependent kinase inhibitors: a potential strategy to counteract drug efflux","volume":"32","author":"Patil","year":"2025","journal-title":"Curr Med Chem"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0222","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0313830","article-title":"Identification of novel cyclin-dependent kinase 4\/6 inhibitors from marine natural products","volume":"20","author":"Debnath","year":"2025","journal-title":"Plos one"},{"issue":"8","key":"10.1016\/j.clbc.2025.09.008_bib0223","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00894-024-06067-z","article-title":"Uncovering potential CDK9 inhibitors from natural compound databases through docking-based virtual screening and MD simulations","volume":"30","author":"Singh","year":"2024","journal-title":"J Mol Model"},{"issue":"6","key":"10.1016\/j.clbc.2025.09.008_bib0224","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s00432-024-05818-y","article-title":"Molecular docking and MD simulation studies of 4-thiazol-N-(pyridin-2-yl) pyrimidin-2-amine derivatives as novel inhibitors targeted to CDK2\/4\/6","volume":"150","author":"Liang","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"issue":"10","key":"10.1016\/j.clbc.2025.09.008_bib0225","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1021\/acsmedchemlett.4c00337","article-title":"Identification of potent CDK9 inhibitors with novel skeletons via virtual screening, biological evaluation, and molecular dynamics simulation","volume":"15","author":"Yang","year":"2024","journal-title":"ACS Med Chem Lett"},{"issue":"17","key":"10.1016\/j.clbc.2025.09.008_bib0226","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1021\/acs.jcim.4c01196","article-title":"Elucidating the selective mechanism of drugs targeting cyclin-dependent kinases with integrated MetaD-US simulation","volume":"64","author":"Wang","year":"2024","journal-title":"J Chem Inf Model"},{"issue":"22","key":"10.1016\/j.clbc.2025.09.008_bib0227","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e40345","article-title":"Computational design of CDK1 inhibitors with enhanced target affinity and drug-likeness using deep-learning framework","volume":"10","author":"Lu","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.clbc.2025.09.008_bib0228","first-page":"1","article-title":"Identification of the potential Pan-CDK antagonists: tracing the path of virtual screening and inhibitory activity on lung cancer cells","author":"Tao","year":"2024","journal-title":"Mol Divers"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0229","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1021\/acs.jmedchem.4c01686","article-title":"Elucidating binding selectivity in cyclin-dependent kinases 4, 6, and 9: development of highly potent and selective CDK4\/9 inhibitors","volume":"68","author":"Jiang","year":"2025","journal-title":"J Med Chem"},{"issue":"6","key":"10.1016\/j.clbc.2025.09.008_bib0230","first-page":"5377","article-title":"Potent inhibitors targeting cyclin-dependent kinase 9 discovered via virtual high-throughput screening and absolute binding free energy calculations","volume":"26","author":"Wang","year":"2024","journal-title":"Phys Chem"},{"issue":"20","key":"10.1016\/j.clbc.2025.09.008_bib0231","doi-asserted-by":"crossref","first-page":"9209","DOI":"10.1021\/acs.jctc.4c01097","article-title":"Integrating molecular dynamics and machine learning algorithms to predict the functional profile of kinase ligands","volume":"20","author":"Frasnetti","year":"2024","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.clbc.2025.09.008_bib0232","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.108111","article-title":"Identification of mitoxantrone as a potent inhibitor of CDK7\/Cyclin H via structure-based virtual screening and In-Vitro validation by ADP-Glo kinase assay","volume":"155","author":"Somarowthu","year":"2025","journal-title":"Bioorg Chem"},{"issue":"11","key":"10.1016\/j.clbc.2025.09.008_bib0233","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/prot.26729","article-title":"Multiple functional protein\u2013protein interaction interfaces allosterically regulate ATP-binding in cyclin-dependent kinase-1","volume":"92","author":"Vishwakarma","year":"2024","journal-title":"Proteins"},{"key":"10.1016\/j.clbc.2025.09.008_bib0234","first-page":"1","article-title":"Exploring natural compounds as potential CDK4 inhibitors for therapeutic intervention in neurodegenerative diseases through computational analysis","author":"Rani","year":"2024","journal-title":"Mol Biotechnol"},{"issue":"47","key":"10.1016\/j.clbc.2025.09.008_bib0235","doi-asserted-by":"crossref","first-page":"34537","DOI":"10.1039\/D4RA06500J","article-title":"Discovery of pyrazole-based analogs as CDK2 inhibitors with apoptotic-inducing activity: design, synthesis and molecular dynamics study","volume":"14","author":"Ali","year":"2024","journal-title":"RSC Adv"},{"key":"10.1016\/j.clbc.2025.09.008_bib0236","article-title":"Exploring the binding characteristics of bovine serum albumin with CDK4\/6 inhibitors Ribociclib: multi-spectral analysis and molecular simulation studies","volume":"258","author":"Jiang","year":"2024","journal-title":"J Photochem Photobiol Bio"},{"issue":"8","key":"10.1016\/j.clbc.2025.09.008_bib0237","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1021\/acs.jmedchem.3c01832","article-title":"Design and synthesis of novel macrocyclic derivatives as potent and selective cyclin-dependent kinase 7 inhibitors","volume":"67","author":"Niu","year":"2024","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0238","article-title":"The novel selective inhibitors of cyclin-dependent kinase 4\/6: in vitro and in silico study","volume":"14","author":"Susanti","year":"2024","journal-title":"Scientific Rep"},{"issue":"5","key":"10.1016\/j.clbc.2025.09.008_bib0239","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1021\/jacsau.4c00138","article-title":"CDK2 and CDK4: cell cycle functions evolve distinct, catalysis-competent conformations, offering drug targets","volume":"4","author":"Zhang","year":"2024","journal-title":"JACS Au"},{"issue":"3","key":"10.1016\/j.clbc.2025.09.008_bib0240","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1080\/07391102.2023.2291546","article-title":"Design of small molecules for CDK-2 inhibition in colorectal cancer based on substructure search","volume":"43","author":"Ogbodo","year":"2025","journal-title":"J Biomol Struct Dyn"},{"issue":"39","key":"10.1016\/j.clbc.2025.09.008_bib0241","doi-asserted-by":"crossref","first-page":"9315","DOI":"10.1021\/acs.jpcb.4c03243","article-title":"Binding modalities and phase-specific regulation of cyclin\/cyclin-dependent kinase complexes in the cell cycle","volume":"128","author":"Bergman","year":"2024","journal-title":"J Phy Chem B"},{"issue":"11","key":"10.1016\/j.clbc.2025.09.008_bib0242","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2174\/1871520618666180510121431","article-title":"Selection of a GPER1 ligand via ligand-based virtual screening coupled to molecular dynamics simulations and its anti-proliferative effects on breast cancer cells","volume":"18","author":"Mart\u00ednez-Mu\u00f1oz","year":"2018","journal-title":"Anticancer Agents Med Chem"},{"issue":"4","key":"10.1016\/j.clbc.2025.09.008_bib0243","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3390\/pharmaceutics14040828","article-title":"Towards selective binding to the GLUT5 transporter: synthesis, molecular dynamics and in vitro evaluation of novel C-3-modified 2, 5-Anhydro-D-Mannitol analogs","volume":"14","author":"Rana","year":"2022","journal-title":"Pharmaceutics"},{"issue":"Suppl 2","key":"10.1016\/j.clbc.2025.09.008_bib0244","article-title":"60P ALDH1 isoform landscape in breast cancer: advancing precision therapies with a potent ALDH1A3-selective inhibitor","volume":"10","author":"Constantinescu","year":"2025","journal-title":"ESMO Open"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0245","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3390\/biomedicines12010172","article-title":"PET\/MRI and novel targets for breast cancer","volume":"12","author":"Chung","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.clbc.2025.09.008_bib0246","doi-asserted-by":"crossref","DOI":"10.3389\/fnume.2023.1236565","article-title":"Theranostics in breast cancer","volume":"3","author":"Vorster","year":"2023","journal-title":"Front Nucl Med"},{"issue":"9","key":"10.1016\/j.clbc.2025.09.008_bib0247","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1039\/D4SC06969B","article-title":"Potential theranostics of breast cancer with copper-64\/67 sarcophagine-trastuzumab","volume":"16","author":"Rudd","year":"2025","journal-title":"Chemical Science"},{"issue":"7-9","key":"10.1016\/j.clbc.2025.09.008_bib0248","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/08927022.2024.2331237","article-title":"Design of novel PLK4 inhibitors as TRIM37-amplified breast cancer drugs using 3D-QSAR, molecular docking, and molecular dynamics simulation methods","volume":"50","author":"Zhan","year":"2024","journal-title":"Mol Simul"},{"key":"10.1016\/j.clbc.2025.09.008_bib0249","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pharmthera.2017.02.007","article-title":"Anti-mitotic agents: are they emerging molecules for cancer treatment?","volume":"173","author":"Penna","year":"2017","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.clbc.2025.09.008_bib0250","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejmech.2014.09.051","article-title":"Recent developments in tubulin polymerization inhibitors: an overview","volume":"87","author":"Kaur","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.clbc.2025.09.008_bib0251","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.ejmech.2017.11.062","article-title":"Recent advances in microtubule-stabilizing agents","volume":"143","author":"Cao","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.clbc.2025.09.008_bib0252","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109784","article-title":"Discovery of microtubule stabilizers with novel scaffold structures based on virtual screening, biological evaluation, and molecular dynamics simulation","volume":"352","author":"Mao","year":"2022","journal-title":"Chem Biol Interact"},{"issue":"19","key":"10.1016\/j.clbc.2025.09.008_bib0253","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.1016\/j.bmcl.2009.08.045","article-title":"Using the golden triangle to optimize clearance and oral absorption","volume":"19","author":"Johnson","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"issue":"22","key":"10.1016\/j.clbc.2025.09.008_bib0254","doi-asserted-by":"crossref","first-page":"10026","DOI":"10.1021\/acs.jmedchem.9b00004","article-title":"Are we opening the door to a new era of medicinal chemistry or being collapsed to a chemical singularity?","volume":"62","author":"Ivanenkov","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.clbc.2025.09.008_bib0255","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jmgm.2013.05.008","article-title":"Similarity-based virtual screening for microtubule stabilizers reveals novel antimitotic scaffold","volume":"44","author":"Ayoub","year":"2013","journal-title":"J Mol Graph Model"},{"issue":"16","key":"10.1016\/j.clbc.2025.09.008_bib0256","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1016\/j.bmcl.2014.06.041","article-title":"Discovery of novel 1, 5-benzodiazepine-2, 4-dione derivatives as potential anticancer agents","volume":"24","author":"Chen","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.clbc.2025.09.008_bib0257","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.antiviral.2014.04.006","article-title":"Arbidol as a broad-spectrum antiviral: an update","volume":"107","author":"Blaising","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.clbc.2025.09.008_bib0258","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112245","article-title":"Indole-based derivatives as potential antibacterial activity against methicillin-resistance Staphylococcus aureus (MRSA)","volume":"194","author":"Qin","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.clbc.2025.09.008_bib0259","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103706","article-title":"Identification of natural products as selective PTP1B inhibitors via virtual screening","volume":"98","author":"Yang","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.clbc.2025.09.008_bib0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111691","article-title":"Indole: a privileged scaffold for the design of anti-cancer agents","volume":"183","author":"Wan","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.clbc.2025.09.008_bib0261","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105486","article-title":"Discovery of novel tubulin inhibitors targeting the colchicine binding site via virtual screening, structural optimization and antitumor evaluation","volume":"118","author":"Liu","year":"2022","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.clbc.2025.09.008_bib0262","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112359","article-title":"Current scenario of indole derivatives with potential anti-drug-resistant cancer activity","volume":"200","author":"Jia","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0263","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-66877-2","article-title":"QSAR, ADMET, molecular docking, and dynamics studies of 1, 2, 4-triazine-3 (2H)-one derivatives as tubulin inhibitors for breast cancer therapy","volume":"14","author":"Moussaoui","year":"2024","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.clbc.2025.09.008_bib0264","article-title":"Identification of new potential microtubule stabilizers via virtual screen, anti-tumor evaluation, and molecular dynamics simulation","volume":"126","author":"Zhang","year":"2025","journal-title":"J Cell Biochem"},{"issue":"10","key":"10.1016\/j.clbc.2025.09.008_bib0265","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1021\/acs.jcim.4c00438","article-title":"Targeting an old foe for cancer: a molecular dynamics perspective to unravel the specific binding nature of 2-methoxy estradiol to human \u03b2-tubulin isotypes","volume":"64","author":"Kumari","year":"2024","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.clbc.2025.09.008_bib0266","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116804","article-title":"Discovery of a novel microtubule destabilizing agent targeting the colchicine site based on molecular docking","author":"Cai","year":"2025","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.clbc.2025.09.008_bib0267","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138465","article-title":"Design, synthesis, and evaluation of anti-breast cancer activity of colchicine-combretastatin A-4 analogues containing quinoline as microtubule-targeting agents","volume":"1312","author":"Doan","year":"2024","journal-title":"J Mol Struct"},{"issue":"31","key":"10.1016\/j.clbc.2025.09.008_bib0268","doi-asserted-by":"crossref","first-page":"22092","DOI":"10.1039\/D4RA04371E","article-title":"Exploring the antitumor potential of novel quinoline derivatives via tubulin polymerization inhibition in breast cancer; design, synthesis and molecular docking","volume":"14","author":"Abdelmegeed","year":"2024","journal-title":"RSC Adv"},{"issue":"10","key":"10.1016\/j.clbc.2025.09.008_bib0269","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.3390\/molecules29102400","article-title":"Antiproliferative and pro-apoptotic activity and tubulin dynamics modulation of 1 H-Benzimidazol-2-yl Hydrazones in human breast cancer cell line MDA-MB-231","volume":"29","author":"Yancheva","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.clbc.2025.09.008_bib0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107827","article-title":"Unveiling the anti-cancer potentiality of phthalimide-based analogues targeting tubulin polymerization in MCF-7 cancerous cells: rational design, chemical synthesis, and biological-coupled computational investigation","author":"Aljuhani","year":"2024","journal-title":"Bioorg Chem"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0271","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1021\/jacs.4c11820","article-title":"Microtubule-targeting NAP peptide-Ru (II)-polypyridyl conjugate as a bimodal therapeutic agent for triple negative breast carcinoma","volume":"147","author":"Chatterjee","year":"2024","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.clbc.2025.09.008_bib0272","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116458","article-title":"Design, synthesis and biological evaluation of novel tubulin-targeting agents with a dual-mechanism for polymerization inhibition and protein degradation","volume":"272","author":"Wang","year":"2024","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0273","doi-asserted-by":"crossref","DOI":"10.1515\/chem-2024-0041","article-title":"3D-QSAR, molecular docking, ADMET, simulation dynamic, and retrosynthesis studies on new styrylquinolines derivatives against breast cancer","volume":"22","author":"EL-Mernissi","year":"2024","journal-title":"Open Chem"},{"key":"10.1016\/j.clbc.2025.09.008_bib0274","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116205","article-title":"Novel 4-Aryl-4H-chromene derivative displayed excellent in vivo anti-glioblastoma efficacy as the microtubule-targeting agent","volume":"267","author":"Yang","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.clbc.2025.09.008_bib0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122836","article-title":"Next generation antimitotic \u03b2-carboline derivatives modulate microtubule dynamics and downregulate NF-\u03baB, ERK 1\/2 and phospho HSP 27","volume":"351","author":"Jash","year":"2024","journal-title":"Life Sci"},{"issue":"11","key":"10.1016\/j.clbc.2025.09.008_bib0276","doi-asserted-by":"crossref","first-page":"9227","DOI":"10.1021\/acs.jmedchem.4c00388","article-title":"Development of potent microtubule targeting agent by structural simplification of natural diazonamide","volume":"67","author":"Kalnins","year":"2024","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0277","first-page":"1","article-title":"Microtubule-modulating drugs alter sensitivity to isoflurane in mice","volume":"25","author":"Li","year":"2025","journal-title":"BMC Anesthesiol"},{"issue":"5","key":"10.1016\/j.clbc.2025.09.008_bib0278","first-page":"949","article-title":"New dynamic scoring method for deep evaluation of naloxegol as \u03b2-tubulin binding inhibitor","volume":"37","author":"Sheikh","year":"2024","journal-title":"Pak J Pharm Sci"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0279","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.1038\/s41467-024-53139-y","article-title":"HURP binding to the vinca domain of \u03b2-tubulin accounts for cancer drug resistance","volume":"15","author":"Saju","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.clbc.2025.09.008_bib0280","doi-asserted-by":"crossref","first-page":"571","DOI":"10.5604\/17322693.1102294","article-title":"Curcumin in chemoprevention of breast cancer","volume":"68","author":"Terlikowska","year":"2014","journal-title":"Postepy Hig Med Dosw"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0281","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4048\/jbc.2013.16.2.133","article-title":"The effect of curcumin on breast cancer cells","volume":"16","author":"Liu","year":"2013","journal-title":"J Breast Cancer"},{"issue":"6","key":"10.1016\/j.clbc.2025.09.008_bib0282","first-page":"9093","article-title":"Targeted therapy of triple negative MDA\u2011MB\u2011468 breast cancer with curcumin delivered by epidermal growth factor\u2011conjugated phospholipid nanoparticles","volume":"15","author":"Jung","year":"2018","journal-title":"Oncol Lett"},{"issue":"10","key":"10.1016\/j.clbc.2025.09.008_bib0283","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2174\/1871520615666150520093644","article-title":"Effect of curcumin on pro-angiogenic factors in the xenograft model of breast cancer","volume":"15","author":"Carvalho Ferreira","year":"2015","journal-title":"Anticancer Agents Med Chem"},{"issue":"20","key":"10.1016\/j.clbc.2025.09.008_bib0284","doi-asserted-by":"crossref","first-page":"7490","DOI":"10.1158\/1078-0432.CCR-05-1192","article-title":"Curcumin suppresses the paclitaxel-induced nuclear factor-\u03baB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice","volume":"11","author":"Aggarwal","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0285","doi-asserted-by":"crossref","DOI":"10.1615\/JEnvironPatholToxicolOncol.v31.i2.40","article-title":"Diosgenin, a steroidal saponin, exhibits anticancer activity by attenuating lipid peroxidation via enhancing antioxidant defense system during NMU-induced breast carcinoma","volume":"31","author":"Jagadeesan","year":"2012","journal-title":"J Environ Pathol Toxicol Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2025.09.008_bib0286","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.phymed.2014.02.002","article-title":"Diosgenin inhibits the migration of human breast cancer MDA-MB-231 cells by suppressing Vav2 activity","volume":"21","author":"He","year":"2014","journal-title":"Phytomedicine"},{"key":"10.1016\/j.clbc.2025.09.008_bib0287","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.abb.2015.12.001","article-title":"The anticancer potential of steroidal saponin, dioscin, isolated from wild yam (Dioscorea villosa) root extract in invasive human breast cancer cell line MDA-MB-231 in vitro","volume":"591","author":"Aumsuwan","year":"2016","journal-title":"Arch Biochem Biophys"},{"issue":"12","key":"10.1016\/j.clbc.2025.09.008_bib0288","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.7314\/APJCP.2014.15.12.5001","article-title":"Garcinol, an acetyltransferase inhibitor, suppresses proliferation of breast cancer cell line MCF-7 promoted by 17\u03b2-estradiol","volume":"15","author":"Ye","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"issue":"10","key":"10.1016\/j.clbc.2025.09.008_bib0289","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1158\/1535-7163.MCT-12-0232-T","article-title":"Garcinol regulates EMT and Wnt signaling pathways in vitro and in vivo, leading to anticancer activity against breast cancer cells","volume":"11","author":"Ahmad","year":"2012","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"10.1016\/j.clbc.2025.09.008_bib0290","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.3892\/mmr.2014.2907","article-title":"Potential therapeutic mechanism of genistein in breast cancer involves inhibition of cell cycle regulation","volume":"11","author":"Zhang","year":"2015","journal-title":"Mol Med Rep"},{"issue":"6","key":"10.1016\/j.clbc.2025.09.008_bib0291","first-page":"1095","article-title":"Transcripional activity of genes encoding MMPs and TIMPs in breast cancer cells treated by genistein and in normal cancer-associated fibroblasts-in vitro studies","volume":"71","author":"Latocha","year":"2014","journal-title":"Acta Pol Pharm"},{"issue":"41","key":"10.1016\/j.clbc.2025.09.008_bib0292","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1038\/onc.2017.164","article-title":"Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3","volume":"36","author":"Sengupta","year":"2017","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0293","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.canlet.2008.11.029","article-title":"Down-regulation of c-Src\/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells","volume":"277","author":"Park","year":"2009","journal-title":"Cancer lett"},{"issue":"18","key":"10.1016\/j.clbc.2025.09.008_bib0294","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.3844","article-title":"Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-\u03b2-catenin signaling axis in a microRNA-34a dependent manner","volume":"6","author":"Avtanski","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.clbc.2025.09.008_bib0295","doi-asserted-by":"crossref","first-page":"412","DOI":"10.12659\/MSM.908022","article-title":"Quercetin inhibits breast cancer stem cells via downregulation of aldehyde dehydrogenase 1A1 (ALDH1A1), chemokine receptor type 4 (CXCR4), mucin 1 (MUC1), and epithelial cell adhesion molecule (EpCAM)","volume":"24","author":"Wang","year":"2018","journal-title":"Med Sci Monit"},{"issue":"5","key":"10.1016\/j.clbc.2025.09.008_bib0296","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3892\/etm.2013.1285","article-title":"Effects of quercetin on the proliferation of breast cancer cells and expression of survivin in vitro","volume":"6","author":"Deng","year":"2013","journal-title":"Exp Ther Med"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0297","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.6","article-title":"Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death","volume":"7","author":"Venkatadri","year":"2016","journal-title":"Cell Death Dis"},{"issue":"8","key":"10.1016\/j.clbc.2025.09.008_bib0298","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1002\/jcb.24134","article-title":"Resveratrol chemosensitizes breast cancer cells to melphalan by cell cycle arrest","volume":"113","author":"Casanova","year":"2012","journal-title":"J Cell Biochem"},{"issue":"8","key":"10.1016\/j.clbc.2025.09.008_bib0299","doi-asserted-by":"crossref","first-page":"11397","DOI":"10.1007\/s13277-016-5000-7","article-title":"Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-\u03b22 expression","volume":"37","author":"Kim","year":"2016","journal-title":"Tumor Biol"},{"key":"10.1016\/j.clbc.2025.09.008_bib0300","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.ejmech.2017.11.007","article-title":"Design and synthesis of novel C14-urea-tetrandrine derivatives with potent anti-cancer activity","volume":"143","author":"Lan","year":"2018","journal-title":"Eur J Med Chem"},{"issue":"5","key":"10.1016\/j.clbc.2025.09.008_bib0301","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.bcp.2011.05.030","article-title":"Anticancer activity of thymoquinone in breast cancer cells: possible involvement of PPAR-\u03b3 pathway","volume":"82","author":"Woo","year":"2011","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0302","doi-asserted-by":"crossref","first-page":"268","DOI":"10.35311\/jmpi.v10i1.520","article-title":"Identifikasi Metabolit Bioaktif pada Asam Jawa (Tamarindus indica L.) menggunakan Komputasi Dinamika Molekuler untuk Penargetan HER-2 Kanker Payudara","volume":"10","author":"Ramadhan","year":"2024","journal-title":"J Mandala Pharmacon Indones"},{"key":"10.1016\/j.clbc.2025.09.008_bib0303","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140851","article-title":"Fabrication of amorphous solid dispersion of Entacapone for enhanced solubility and dissolution rate: morphology, solid state characterization, in silico molecular docking studies","volume":"1324","author":"Dhuri","year":"2025","journal-title":"J Mol Struct"},{"issue":"3","key":"10.1016\/j.clbc.2025.09.008_bib0304","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1080\/07391102.2023.2198017","article-title":"Integrated virtual screening and molecular dynamics simulation approaches revealed potential natural inhibitors for DNMT1 as therapeutic solution for triple negative breast cancer","volume":"42","author":"Bashir","year":"2024","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0305","doi-asserted-by":"crossref","first-page":"6768","DOI":"10.1038\/s41598-024-55321-0","article-title":"Targeting human progesterone receptor (PR), through pharmacophore-based screening and molecular simulation revealed potent inhibitors against breast cancer","volume":"14","author":"Shahab","year":"2024","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.clbc.2025.09.008_bib0306","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202301903","article-title":"Computational exploration of naturally occurring flavonoids as TGF-\u03b2 inhibitors in breast cancer: insights from docking and molecular dynamics simulations and in-vitro cytotoxicity study","volume":"21","author":"Shah","year":"2024","journal-title":"Chem Biodivers"},{"issue":"5","key":"10.1016\/j.clbc.2025.09.008_bib0307","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1080\/07391102.2023.2208215","article-title":"Identification of indole-based natural compounds as inhibitors of PARP-1 against triple-negative breast cancer: a computational study","volume":"42","author":"Priyankha","year":"2024","journal-title":"J Biomol Struct Dyn"},{"issue":"17","key":"10.1016\/j.clbc.2025.09.008_bib0308","doi-asserted-by":"crossref","first-page":"9076","DOI":"10.1080\/07391102.2023.2250449","article-title":"Discovery of pharmacological agents for triple-negative breast cancer (TNBC): molecular docking and molecular dynamic simulation studies on 5-lipoxygenase (5-LOX) and nuclear factor kappa B (NF-\u03baB)","volume":"42","author":"Kundu","year":"2024","journal-title":"J Biomol Struct Dyn"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0309","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3390\/md22020083","article-title":"Identification of PLK1-PBD inhibitors from the library of marine natural products: 3D QSAR pharmacophore, ADMET, scaffold hopping, molecular docking, and molecular dynamics study","volume":"22","author":"Zhou","year":"2024","journal-title":"Mar Drugs"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0310","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s40203-024-00258-5","article-title":"Marine natural compounds as potential CBP bromodomain inhibitors for treating cancer: an in-silico approach using molecular docking, ADMET, molecular dynamics simulations and MM-PBSA binding free energy calculations","volume":"12","author":"Ali","year":"2024","journal-title":"In Silico Pharmacol"},{"key":"10.1016\/j.clbc.2025.09.008_bib0311","first-page":"1","article-title":"Virtual screening and molecular dynamics simulation of natural compounds as potential inhibitors of serine\/threonine kinase 16 for anticancer drug discovery","author":"Al-Fahad","year":"2024","journal-title":"Mol Divers"},{"issue":"7","key":"10.1016\/j.clbc.2025.09.008_bib0312","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1080\/07391102.2023.2218938","article-title":"Identification of natural product-based effective inhibitors of spleen tyrosine kinase (SYK) through virtual screening and molecular dynamics simulation approaches","volume":"42","author":"Ali","year":"2024","journal-title":"J Biomol Struct Dyn"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0313","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3390\/molecules22020308","article-title":"Natural products as chemopreventive agents by potential inhibition of the kinase domain in ErbB receptors","volume":"22","author":"Olivero-Acosta","year":"2017","journal-title":"Molecules"},{"issue":"13","key":"10.1016\/j.clbc.2025.09.008_bib0314","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1080\/07391102.2021.1877823","article-title":"Molecular docking and molecular dynamic studies: screening of phytochemicals against EGFR, HER2, estrogen and NF-KB receptors for their potential use in breast cancer","volume":"40","author":"Purawarga Matada","year":"2022","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.clbc.2025.09.008_bib0315","first-page":"1","article-title":"Anticancer potential of Cu (II) prolinedithiocarbamate complex: design, synthesis, spectroscopy, molecular docking, molecular dynamic, ADMET, and in-vitro studies","author":"Irfandi","year":"2023","journal-title":"J Biomol Struct Dyn"},{"issue":"4","key":"10.1016\/j.clbc.2025.09.008_bib0316","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.biotechadv.2016.04.002","article-title":"Nanotechnology for the delivery of phytochemicals in cancer therapy","volume":"34","author":"Xie","year":"2016","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.clbc.2025.09.008_bib0317","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.664380","article-title":"Nanomaterial complexes enriched with natural compounds used in cancer therapies: a perspective for clinical application","volume":"11","author":"Saavedra-Leos","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.clbc.2025.09.008_bib0318","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jare.2019.02.036","article-title":"pH-responsive and targeted delivery of curcumin via phenylboronic acid-functionalized ZnO nanoparticles for breast cancer therapy","volume":"18","author":"Kundu","year":"2019","journal-title":"J Adv Res"},{"issue":"44","key":"10.1016\/j.clbc.2025.09.008_bib0319","doi-asserted-by":"crossref","first-page":"14927","DOI":"10.1039\/D1SC05562C","article-title":"Structure prediction of cyclic peptides by molecular dynamics+ machine learning","volume":"12","author":"Miao","year":"2021","journal-title":"Chem Sci"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0320","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41392-024-02036-3","article-title":"New insights into protein\u2013protein interaction modulators in drug discovery and therapeutic advance","volume":"9","author":"Nada","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"24","key":"10.1016\/j.clbc.2025.09.008_bib0321","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.3390\/cells11244016","article-title":"Recent advances of studies on cell-penetrating peptides based on molecular dynamics simulations","volume":"11","author":"Ouyang","year":"2022","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.clbc.2025.09.008_bib0322","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.70117","article-title":"Computational design of a bicyclic peptide inhibitor targeting the ICOS\/ICOS-L protein\u2013protein interaction","volume":"105","author":"Calvo-Barreiro","year":"2025","journal-title":"Chem Biol Drug Des"},{"issue":"22","key":"10.1016\/j.clbc.2025.09.008_bib0323","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.1021\/acs.jpcb.4c00157","article-title":"Assessing the performance of peptide force fields for modeling the solution structural ensembles of cyclic peptides","volume":"128","author":"Miao","year":"2024","journal-title":"J Phy Chem B"},{"issue":"21","key":"10.1016\/j.clbc.2025.09.008_bib0324","doi-asserted-by":"crossref","first-page":"6925","DOI":"10.1021\/acs.jcim.3c01337","article-title":"Computational prediction of cyclic peptide structural ensembles and application to the design of Keap1 binders","volume":"63","author":"Fonseca Lopez","year":"2023","journal-title":"J Chem Inf Model"},{"issue":"14","key":"10.1016\/j.clbc.2025.09.008_bib0325","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1021\/acs.jctc.3c00154","article-title":"Training neural network models using molecular dynamics simulation results to efficiently predict cyclic hexapeptide structural ensembles","volume":"19","author":"Hui","year":"2023","journal-title":"J Chem Theory Comput"},{"issue":"22","key":"10.1016\/j.clbc.2025.09.008_bib0326","doi-asserted-by":"crossref","first-page":"15123","DOI":"10.1021\/acs.jmedchem.2c00968","article-title":"In silico exploration and biological evaluation of bispecific peptides derived from anti-HER2 antibodies and peptide\u2013camptothecin conjugates for HER2-positive breast cancer","volume":"65","author":"Zhou","year":"2022","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0327","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/app12010515","article-title":"In silico studies of tumor targeted peptide-conjugated natural products for targeting over-expressed receptors in breast cancer cells using molecular docking, molecular dynamics and MMGBSA calculations","volume":"12","author":"Hart","year":"2022","journal-title":"Applied Sci"},{"key":"10.1016\/j.clbc.2025.09.008_bib0328","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106249","article-title":"Peptide-based targeted cancer therapeutics: design, synthesis and biological evaluation","volume":"176","author":"Iwanov","year":"2022","journal-title":"Eur J Pharma Sci"},{"key":"10.1016\/j.clbc.2025.09.008_bib0329","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2024.2335555","article-title":"In silico investigations and molecular insights for designing tRNA-encoded peptides as potential therapeutics for targeting over-expressed receptors in breast cancer","author":"Shanthappa","year":"2024","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.clbc.2025.09.008_bib0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.130573","article-title":"Peptide based nano-drug candidate for cancer treatment: preparation, characterization, in vitro and in silico evaluation","volume":"1240","author":"Bicak","year":"2021","journal-title":"J Mol Struct"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0331","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13065-024-01143-0","article-title":"Computational design of anti-cancer peptides tailored to target specific tumor markers","volume":"18","author":"Naeem","year":"2024","journal-title":"BMC Chem"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0332","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40824-023-00386-7","article-title":"Application of molecular dynamics simulation in self-assembled cancer nanomedicine","volume":"27","author":"Xu","year":"2023","journal-title":"Biomater Res"},{"issue":"6","key":"10.1016\/j.clbc.2025.09.008_bib0333","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.drudis.2021.03.003","article-title":"Computational avenues in oral protein and peptide therapeutics","volume":"26","author":"Pandya","year":"2021","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.clbc.2025.09.008_bib0334","article-title":"Cyclic peptides as an inhibitor of metastasis in breast cancer targeting MMP-1: computational approach","volume":"35","author":"Hasan","year":"2022","journal-title":"Inform Med Unlocked"},{"issue":"4","key":"10.1016\/j.clbc.2025.09.008_bib0335","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1021\/acs.chemrev.0c01087","article-title":"Elucidating solution structures of cyclic peptides using molecular dynamics simulations","volume":"121","author":"Damjanovic","year":"2021","journal-title":"Chemical Rev"},{"issue":"7","key":"10.1016\/j.clbc.2025.09.008_bib0336","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3390\/cells12071078","article-title":"Development of cyclic peptides targeting the epidermal growth factor receptor in mesenchymal triple-negative breast cancer subtype","volume":"12","author":"Nistic\u00f2","year":"2023","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.clbc.2025.09.008_bib0337","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.3390\/ijms25094622","article-title":"Computational design of novel cyclic peptides endowed with autophagy-inhibiting activity on cancer cell lines","volume":"25","author":"Albani","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.clbc.2025.09.008_bib0338","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/1574885518666230222113033","article-title":"Molecular docking and simulation analysis of cyclopeptides as anticancer agents","volume":"18","author":"Tiwari","year":"2023","journal-title":"Curr Drug Ther"},{"issue":"3","key":"10.1016\/j.clbc.2025.09.008_bib0339","doi-asserted-by":"crossref","DOI":"10.1002\/minf.201800089","article-title":"Structure-based discovery of novel CK2\u03b1-binding cyclic peptides with anti-cancer activity","volume":"38","author":"Tang","year":"2019","journal-title":"Mol Inform"},{"issue":"10","key":"10.1016\/j.clbc.2025.09.008_bib0340","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1002\/ptr.7547","article-title":"Molecular dynamics simulation and in vitro evaluation of herb\u2013drug interactions involving dietary polyphenols and CDK inhibitors in breast cancer chemotherapy","volume":"36","author":"Patil","year":"2022","journal-title":"Phytother Res"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0341","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s42485-025-00176-w","article-title":"Exploring phytoconstituents through molecular dynamics simulation: uncovering potential inhibitors for multiple targeted pathways in breast cancer","volume":"16","author":"Isa","year":"2025","journal-title":"J Proteins Proteom"},{"key":"10.1016\/j.clbc.2025.09.008_bib0342","doi-asserted-by":"crossref","DOI":"10.1177\/11779322251316864","article-title":"Molecular docking appraisal of Pleurotus ostreatus phytochemicals as potential inhibitors of PI3K\/Akt pathway for breast cancer treatment","volume":"19","author":"Effiong","year":"2025","journal-title":"Bioinform Biol Insights"},{"issue":"5","key":"10.1016\/j.clbc.2025.09.008_bib0343","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038261","article-title":"Prediction of molecular targets of cancer preventing flavonoid compounds using computational methods","volume":"7","author":"Chen","year":"2012","journal-title":"PloS one"},{"issue":"17","key":"10.1016\/j.clbc.2025.09.008_bib0344","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.1080\/07391102.2020.1802347","article-title":"Identification of polyphenols from Broussonetia papyrifera as SARS CoV-2 main protease inhibitors using in silico docking and molecular dynamics simulation approaches","volume":"39","author":"Ghosh","year":"2021","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0345","article-title":"Binding mode investigation of polyphenols from Scrophularia targeting human aldose reductase using molecular docking and molecular dynamics simulations","volume":"2015","author":"Manivannan","year":"2015","journal-title":"J Chem"},{"issue":"21","key":"10.1016\/j.clbc.2025.09.008_bib0346","doi-asserted-by":"crossref","first-page":"9878","DOI":"10.3390\/app14219878","article-title":"Pharmacoinformatics, molecular dynamics simulation, and quantum mechanics calculation based phytochemical screening of croton bonplandianum against breast cancer by targeting estrogen receptor-\u03b1 (ER\u03b1)","volume":"14","author":"Saha","year":"2024","journal-title":"Applied Sciences"},{"key":"10.1016\/j.clbc.2025.09.008_bib0347","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202402864","article-title":"Phytochemical-based drug discovery for breast cancer: combining virtual screening and molecular dynamics to identify novel therapeutics","author":"Durgawale","year":"2025","journal-title":"Chem Biodivers"},{"key":"10.1016\/j.clbc.2025.09.008_bib0348","first-page":"1","article-title":"Exploring phytoconstituents through molecular dynamics simulation: uncovering potential inhibitors for multiple targeted pathways in breast cancer","author":"Isa","year":"2025","journal-title":"J Proteins Proteom"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0349","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10549-023-07107-7","article-title":"Analysing potent biomarkers along phytochemicals for breast cancer therapy: an in silico approach","volume":"203","author":"Shekar","year":"2024","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2025.09.008_bib0350","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.12688\/f1000research.155657.1","article-title":"Molecular docking and MD simulation approach to identify potential phytochemical lead molecule against triple negative breast cancer","volume":"13","author":"Sankaranarayanan","year":"2024","journal-title":"F1000Research"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0351","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s44371-024-00071-1","article-title":"Exploration of marine natural compounds as promising MDM2 inhibitors for treating triple-negative breast cancer: insights from molecular docking, ADME\/T studies, molecular dynamics simulation and MM-PBSA binding free energy calculations","volume":"1","author":"Ali","year":"2024","journal-title":"Discov Chem"},{"issue":"00","key":"10.1016\/j.clbc.2025.09.008_bib0352","first-page":"1","article-title":"Phytochemicals for breast cancer therapeutic intervention: exploratory in silico molecular docking study","volume":"00","author":"Parihar","year":"2024","journal-title":"Medinformatics"},{"issue":"8","key":"10.1016\/j.clbc.2025.09.008_bib0353","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0308913","article-title":"Unveiling the potential of phytochemicals to inhibit nuclear receptor binding SET domain protein 2 for cancer: pharmacophore screening, molecular docking, ADME properties, and molecular dynamics simulation investigations","volume":"19","author":"Mohamed","year":"2024","journal-title":"Plos one"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0354","doi-asserted-by":"crossref","first-page":"52","DOI":"10.54005\/geneltip.1494859","article-title":"Exploring therapeutic potentials of natural agents against breast cancer using molecular modeling","volume":"35","author":"Sazl\u0131","year":"2025","journal-title":"Genel T\u0131p Dergisi"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0355","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1038\/s41598-024-84401-4","article-title":"Comprehensive pharmacokinetic profiling and molecular docking analysis of natural bioactive compounds targeting oncogenic biomarkers in breast cancer","volume":"15","author":"Othman","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0356","doi-asserted-by":"crossref","DOI":"10.2174\/0115701638295736240315105737","article-title":"Repurposing phytochemicals against breast cancer (MCF-7) using classical structure-based drug design","volume":"22","author":"Aldoghachi","year":"2025","journal-title":"Curr Drug Discov Technol"},{"issue":"2","key":"10.1016\/j.clbc.2025.09.008_bib0357","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e41897","article-title":"Identification of natural phytochemicals as AKT2 inhibitors using molecular docking and dynamics simulations as potential cancer therapeutics","volume":"11","author":"Paul","year":"2025","journal-title":"Heliyon"},{"issue":"19","key":"10.1016\/j.clbc.2025.09.008_bib0358","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1063\/1.470117","article-title":"A smooth particle mesh Ewald method","volume":"103","author":"Essmann","year":"1995","journal-title":"J Chem Phys"},{"issue":"1","key":"10.1016\/j.clbc.2025.09.008_bib0359","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev.biophys.28.1.155","article-title":"Molecular dynamics simulations of biomolecules: long-range electrostatic effects","volume":"28","author":"Sagui","year":"1999","journal-title":"Annu Rev Biophys Biomol Struct"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820925002770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820925002770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T18:59:13Z","timestamp":1763751553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820925002770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":361,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1526820925002770"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2025.09.008","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From Molecules to Medicine: Molecular Dynamics and Docking in Breast Cancer Therapeutics","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2025.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}